These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience. Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117 [TBL] [Abstract][Full Text] [Related]
45. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Eskelin S; Pyrhönen S; Summanen P; Hahka-Kemppinen M; Kivelä T Ophthalmology; 2000 Aug; 107(8):1443-9. PubMed ID: 10919885 [TBL] [Abstract][Full Text] [Related]
46. [Uveal melanoma: the challenge to save more lives]. Barrio Barrio J Arch Soc Esp Oftalmol; 2005 Nov; 80(11):629-30. PubMed ID: 16311949 [No Abstract] [Full Text] [Related]
47. Survival from uveal melanoma in Western Australia 1981-2005. Chew AL; Spilsbury K; Isaacs TW Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534 [TBL] [Abstract][Full Text] [Related]
48. Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population. Shibayama Y; Namikawa K; Sone M; Takahashi A; Tsutsumida A; Sugawara S; Arai Y; Aihara Y; Suzuki S; Nakayama J; Imafuku S; Yamazaki N Int J Clin Oncol; 2017 Jun; 22(3):577-584. PubMed ID: 28144882 [TBL] [Abstract][Full Text] [Related]
49. Geographic disparities in diagnostic screening for metastatic uveal melanoma. Gombos DS; Van Quill KR; Uusitalo M; O'Brien JM Ophthalmology; 2004 Dec; 111(12):2254-8. PubMed ID: 15582082 [TBL] [Abstract][Full Text] [Related]
50. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls. Valsecchi ME; Orloff M; Sato R; Chervoneva I; Shields CL; Shields JA; Mastrangelo MJ; Sato T Ophthalmology; 2018 Feb; 125(2):210-217. PubMed ID: 28935400 [TBL] [Abstract][Full Text] [Related]
52. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. Vogl T; Eichler K; Zangos S; Herzog C; Hammerstingl R; Balzer J; Gholami A J Cancer Res Clin Oncol; 2007 Mar; 133(3):177-84. PubMed ID: 17021903 [TBL] [Abstract][Full Text] [Related]
53. Uveal melanoma: update and future directions. Rousseau AP Can J Ophthalmol; 2004 Jun; 39(4):335-42. PubMed ID: 15327097 [TBL] [Abstract][Full Text] [Related]
54. Update on the management of posterior uveal melanoma. Zhao DY; Shields CL; Shields JA; Gunduz K J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975 [TBL] [Abstract][Full Text] [Related]
55. Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies. Komatsubara KM; Carvajal RD Curr Oncol Rep; 2017 Jul; 19(7):45. PubMed ID: 28508938 [TBL] [Abstract][Full Text] [Related]